| Title |
Prevalence of Musculoskeletal Pain and Statin Use
|
|---|---|
| Published in |
Journal of General Internal Medicine, May 2008
|
| DOI | 10.1007/s11606-008-0636-7 |
| Pubmed ID | |
| Authors |
Catherine Buettner, Roger B. Davis, Suzanne G. Leveille, Murray A. Mittleman, Kenneth J. Mukamal |
| Abstract |
Muscle effects are the most common reported adverse effects of 3-hydroxy-3-methylglutaryl coenzyme A inhibitors (statins). However, in placebo-controlled trials the incidence of muscle pain is most often similar for placebo and active control groups. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 1 | 25% |
| United Kingdom | 1 | 25% |
| Unknown | 2 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 99 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 2% |
| Canada | 2 | 2% |
| Belgium | 1 | 1% |
| United Kingdom | 1 | 1% |
| Unknown | 93 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 14 | 14% |
| Student > Master | 13 | 13% |
| Student > Bachelor | 12 | 12% |
| Other | 10 | 10% |
| Student > Ph. D. Student | 9 | 9% |
| Other | 20 | 20% |
| Unknown | 21 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 41 | 41% |
| Agricultural and Biological Sciences | 10 | 10% |
| Nursing and Health Professions | 6 | 6% |
| Biochemistry, Genetics and Molecular Biology | 5 | 5% |
| Psychology | 3 | 3% |
| Other | 12 | 12% |
| Unknown | 22 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 September 2023.
All research outputs
#2,091,409
of 25,490,562 outputs
Outputs from Journal of General Internal Medicine
#1,584
of 8,208 outputs
Outputs of similar age
#5,176
of 89,337 outputs
Outputs of similar age from Journal of General Internal Medicine
#11
of 50 outputs
Altmetric has tracked 25,490,562 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,208 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.1. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 89,337 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.